U.S. market Closed. Opens in 2 days 6 hours 20 minutes

SCLX | Scilex Holding Company Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.4559 - 0.5448
52 Week Range 0.4559 - 2.6300
Beta 2.32
Implied Volatility 190.58%
IV Rank 38.65%
Day's Volume 3,349,939
Average Volume 1,906,123
Shares Outstanding 191,791,000
Market Cap 99,884,753
Sector Healthcare
Industry Drug Manufacturers - General
IPO Date 2021-03-05
Valuation
Profitability
Growth
Health
P/E Ratio -0.36
Forward P/E Ratio N/A
EPS -1.44
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 113
Country USA
Website SCLX
Scilex Holding Co is engaged in the development and commercialization of non-opioid pain management products. The company's lead product ZTlido.
SCLX's peers: AZN, HZNP, GILD, BMY, AMGN, LLY, ABBV, MRK, BIIB, SNY, NVS, GSK
*Chart delayed
Analyzing fundamentals for SCLX we got that it has weak fundamentals where Valuation is considered to be overvalued, Profitability is unacceptably poor, Growth is bad and Health is frighteningly weak. For more detailed analysis please see SCLX Fundamentals page.

Watching at SCLX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SCLX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙